Cytokinetics
CYTK
CYTK
181 hedge funds and large institutions have $1.47B invested in Cytokinetics in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 86 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+23
Holders Change %
+14.56%
% of All Funds
3.66%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
43
Increased
86
Reduced
36
Closed
20
Calls
$62.7M
Puts
$50.4M
Net Calls
+$12.3M
Net Calls Change
+$14.9M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$71.9M |
| 2 |
RI
RTW Investments
New York
|
$40.7M |
| 3 |
BlackRock
New York
|
$233M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
$34.8M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$55.2M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
$0 |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
$0 |
| 3 |
Jennison Associates
New York
|
$5.85M |
| 4 |
Invesco
Atlanta,
Georgia
|
$9.33M |
| 5 |
EP
Eversept Partners
New York
|
$0 |
